>
Flights Diverted as SpaceX Starship Self-Destructs Over Caribbean
Marco Rubio testifies at Senate hearing for secretary of state confirmation
Here's the confirmation hearing schedule for Trump's Cabinet picks
Do Not Consent to Health Tyranny
$200 gadget brings global satellite texting to any smartphone
New Study Confirms that Cancer Cells Ferment Glutamine
eVTOL 'flying motorcycle' promises 40 minutes of flight endurance
New Electric 'Donut Motor' Makes 856 HP but Weighs Just 88 Pounds
Physicists discover that 'impossible' particles could actually be real
Is the world ready for the transformational power of fusion?
Solar EV gets more slippery for production-intent Las Vegas debut
Hydrogen Finally Gets A Price Tag: S&P 500 New Energy Plays Soar Along With This Amazon Vendor
TSMC's New Arizona Fab! Apple Will Finally Make Advanced Chips In The U.S.
Study Reveals Key Alzheimer's Pathway - And Blocking It Reverses Symptoms in Mice
3 patients experienced complete remission after regularly taking fenbendazole.
But the cancer industry seems to hate it because it only costs about $11 per week.
Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects.
The case series highlights the remarkable stories of three cancer patients who achieved miraculous recoveries with fenbendazole after exhausting all conventional therapies.
After analyzing these cases, the abstract concluded, "FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies."
Adding to the growing evidence in support of fendendazole's use case against cancer, an Oklahoma man credited his miraculous cancer recovery to the pet med after overcoming terminal small cell lung cancer, defying a less than 1% survival rate and leaving doctors baffled.
This story is truly remarkable. Watch.